Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Evercore ISI Group Upgrades Bionomics to Outperform, Announces $6 Price Target

Evercore ISI Group Upgrades Bionomics to Outperform, Announces $6 Price Target

Evercore ISI Group analyst Joshua Schimmer upgrades Bionomics (NASDAQ:BNOX) from In-Line to Outperform and announces $6 price target.

March 10, 2023

1 minute read

Evercore ISI Group analyst Joshua Schimmer upgrades Bionomics (NASDAQ:BNOX) from In-Line to Outperform and announces $6 price target.

RBC Capital Reiterates Outperform on Chimera Investment, Maintains $7 Price Target

March 7, 9:01 AM

RBC Capital analyst Kenneth Lee reiterates Chimera Investment (NYSE:CIM) with a Outperform and maintains $7 price target.

October 30, 1:00 PM

Raymond James has decided to maintain its Outperform rating of NOV (NYSE:NOV) and raise its price target from…

April 15, 3:13 AM

Spotify's AI DJ is a part of the company's broader strategy to enhance user experience through AI and machine learning.

October 3, 3:38 PM

Within the last quarter, Regeneron Pharmaceuticals (NASDAQ:REGN) has observed the following analyst ratings: